Navigate / EASA

AMC17 MED.B.095 Medical examination and assessment of applicants for LAPL medical certificates

ED Decision 2019/002/R

ONCOLOGY

(a)     In the case of malignant disease, applicants may be considered for a fit assessment if:

(1)     there is no evidence of residual malignant disease likely to jeopardise flight safety;

(2)     time appropriate to the type of tumour has elapsed since the end of primary treatment;

(3)     the risk of in-flight incapacitation from a recurrence or metastasis is sufficiently low;

(4)     there is no evidence of short or long-term sequelae from treatment that may jeopardise flight safety.

(b)     Arrangements for an oncological follow-up should be made for an appropriate period of time.

(c)      Applicants with an established history or clinical diagnosis of intracerebral malignant tumour should be assessed as unfit.